{
    "2020-04-23": [
        [
            {
                "time": "",
                "original_text": "人福医药回复问询：未向国药股份提出收购宜昌人福少数股权具有合理性 问询",
                "features": {
                    "keywords": [
                        "人福医药",
                        "国药股份",
                        "宜昌人福",
                        "少数股权",
                        "合理性",
                        "问询"
                    ],
                    "sentiment_score": 0.2,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "人福医药、同花顺、紫光股份等56只业绩大增股获机构抢筹",
                "features": {
                    "keywords": [
                        "人福医药",
                        "同花顺",
                        "紫光股份",
                        "业绩大增",
                        "机构抢筹"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "科技",
                        "金融"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}